fda compound tirzepatide Lilly seeks to intervene in compounded lawsuit Tirzepatide, FDA, and Compounding: Understanding

Kent Berridge, professor of psychology and neuroscience at the University of Michigan, has noted that GLP-1 drugs may lower the "wanting" component of pleasure -- the motivational drive toward rewarding experiences -- even if the capacity for "liking" remains intact

Wu, T., Rayner, C

A weekly semaglutide injection may be a good option for patients who want a traditional GLP-1 treatment path with a once-weekly routine

In summary, while semaglutide treatment requires an initial investment, getting your weight under control minimizes future health spending and maximizes quality of life through avoided or delayed chronic conditions